Takamitsu Hattori

10PUBLICATIONS
50CO-AUTHORS
Cancer cell biologyMolecular targetsGlycoconjugatesProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 18, 2026
The integrated stress response promotes immune evasion through lipocalin 2.

Jozef P Bossowski, Ray Pillai, John Kilian

|Dec 17, 2025
Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy.

Lorenzo Maso, Sarah A Mosure, Sergio A Rodriguez-Aponte

|Sep 30, 2025
Engineering antibody-drug conjugates targeting an adhesion GPCR, CD97.

Takamitsu Hattori, Michelle Wang, Alexis D Corrado

|Jul 30, 2025
Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib.

Lorenzo Maso, Epsa Rajak, Takamitsu Hattori

|Jan 10, 2025
Binding mode-guided development of high-performance antibodies targeting site-specific posttranslational modifications.

Mariapia Riso, Rohan N Shah, Akiko Koide

|Oct 22, 2024
Selective targeting of oncogenic hotspot mutations of the HER2 extracellular domain.

Injin Bang, Takamitsu Hattori, Nadia Leloup

Pageof 2